Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
13Dec2025
  • Home
  • About
  • News
  • Subscribe
13Dec2025
Cost Curve NewsCost Curve News
Cost Curve News

Well, It Really Happened. Kennedy Is the Secretary of HHS

It’s official, folks: Robert Kennedy, Jr. is your new Secretary of HHS. (More on that below.) The next question: how long will he last? I want your guess. Here are the
10 months ago
Keep Reading
Cost Curve News

There’s an Abbreviation for Everyone Today: PBM, IRA, 340B, RFK, ICER, NPLB

Most days, I want this newsletter to serve as an opportunity to pause and meaningfully chew on the issues of the day. To layer in context and nuance and snark.
10 months ago
Keep Reading
Cost Curve News

Judge Pauses Trump Effort to Massively Role Back Funding for NIH Grantees

No Curve tomorrow in honor of Charles Darwin’s birthday. If you want to search Cost Curve back issues or link to anything you read here, the web links and archive
10 months ago
Keep Reading
Cost Curve News

Gearing Up for the Battle — and the Battles to Come — Over Innovation

I’m still soliciting thoughts on your must-listen health care podcasts. In my erstwhile hometown of Lincoln, Nebraska, there’s a gorgeous pedestrian bridge that connects the arena to the baseball stadium
10 months ago
Keep Reading
Cost Curve News

340B Is Driving Up Employer Costs by Billions, State-by-State IQVIA Assessment Shows

Happy Friday! I’m hoping to tap into the collective wisdom of the Cost Curve subscriber base again: I’m curious about the health-related podcasts that you listen to.  I have a
10 months ago
Keep Reading
Cost Curve News

Part D Benefit Redesign Will Cost Drug Companies Billions This Year … And That’s OK

Cost Curve is off tomorrow. Time for a breather. Robert Kennedy Jr.’s nomination as HHS secretary is headed to the Senate floor. The group overseeing the process -- the Senate
10 months ago
Keep Reading
Cost Curve News

The Depth of Anger Around Health Care Has Been Laid Bare. Cigna Seems to Recognize that Danger

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
10 months ago
Keep Reading
Cost Curve News

Will the Price Disclosure for Vertex’s Journavx Set a New Standard for Transparency?

Last month, Mel Whittington, who runs the Leerink Center for Pharmacoeconomics, had me on her podcast to discuss the intersection between communications and health economics. I had a blast, and
10 months ago
Keep Reading
Cost Curve News

Kennedy: Not Good on Vaccines, Real Shaky on Medicare and Medicaid

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
11 months ago
Keep Reading
Cost Curve News

‘Nobody Knows’ Is Still a Good Description of the White House Health Policy Plans, But the Joke’s No Longer Funny

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv. For a couple of months
11 months ago
Keep Reading
202122

Latest Posts

A New Tracker for Watching Meds That Might See Prices Slashed

December 10, 2025

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

December 9, 2025

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

December 8, 2025

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

December 5, 2025

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

December 4, 2025

Popular

A New Tracker for Watching Meds That Might See Prices Slashed

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,939)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (2,029)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,921)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,719)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,710)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

A New Tracker for Watching Meds That Might See Prices Slashed

December 10, 2025

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

December 9, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe